CVE-2022-26236 in Remisol Advance
Summary
by MITRE • 10/07/2022
The default privileges for the running service Normand Remisol Advance Launcher in Beckman Coulter Remisol Advance v2.0.12.1 and prior allows non-privileged users to overwrite and manipulate executables and libraries. This allows attackers to access sensitive data.
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Analysis
by VulDB Data Team • 05/08/2026
The vulnerability identified as CVE-2022-26236 resides within the Beckman Coulter Remisol Advance v2.0.12.1 and earlier versions, specifically affecting the Normand Remisol Advance Launcher service. This critical security flaw stems from improper privilege management where the service operates with elevated permissions beyond what is necessary for its intended functionality. The issue manifests through the launcher service's default configuration that grants insufficient access controls, allowing unauthorized users to manipulate critical system components. The vulnerability represents a classic privilege escalation scenario where standard user accounts can leverage the service's elevated privileges to gain deeper system access. This misconfiguration creates an attack surface that directly contradicts the principle of least privilege, which is fundamental to secure system design and is referenced in CWE-276.
The technical implementation of this vulnerability involves the launcher service running with elevated privileges while maintaining file permissions that permit modification of executable files and libraries. Attackers can exploit this by placing malicious binaries in directories that the service processes, effectively enabling code injection attacks. The service's default configuration fails to properly validate file integrity or enforce proper access controls during execution phases. This flaw enables attackers to replace legitimate executables with malicious counterparts, creating a persistent backdoor within the system. The vulnerability is particularly concerning because it allows for arbitrary code execution through the manipulation of system libraries, which can escalate privileges beyond the initial access point. This type of attack vector is categorized under ATT&CK technique T1059 for execution and T1546 for persistence mechanisms, demonstrating how this vulnerability can be leveraged for broader system compromise.
The operational impact of CVE-2022-26236 extends beyond simple privilege escalation to encompass complete system compromise and data exfiltration capabilities. Non-privileged users can leverage this vulnerability to access sensitive data that should be protected by proper access controls, potentially exposing confidential information within laboratory environments. The attack surface is particularly dangerous in research and medical settings where the Remisol Advance system processes proprietary data and sensitive patient information. The vulnerability can be exploited to establish persistent access, modify system configurations, or deploy additional malware payloads. Organizations using this software may experience unauthorized data access, system integrity violations, and potential compliance breaches. The impact is amplified by the fact that the vulnerability exists in the default installation configuration, requiring no specialized knowledge to exploit, making it a significant risk for organizations that have not implemented proper security hardening measures. This vulnerability directly violates security best practices outlined in industry standards such as NIST SP 800-53 and ISO 27001, which emphasize proper access control and privilege management. The exploitation of this vulnerability can result in cascading security failures, where initial access leads to complete system compromise and unauthorized access to critical laboratory data. Organizations should consider this vulnerability as a high-priority threat that requires immediate remediation through software updates or proper privilege configuration adjustments.